TrialDiabetes2015

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans.

Juraj Koska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.